CGP 56999A
Code | Size | Price |
---|
TAR-T26993-5mg | 5mg | £1,171.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26993-50mg | 50mg | £2,303.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26993-100mg | 100mg | £3,042.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CGP 56999A is an antagonist of GABA(B) receptor, it enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum.
CAS:
153994-97-9
Formula:
C19H30NO5P
Molecular Weight:
383.425
Purity:
0.98
SMILES:
C[C@@H](NC[C@H](O)CP(C)(=O)OC1CCCCC1)c1cccc(c1)C(O)=O
References
1. Enna SJ, Reisman SA, Stanford JA. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway. Neurosci Lett. 2006 Oct 2;406(1-2):102-6. PubMed PMID: 16890350.
2. Tsai ML, Crutchley M, Boyce R, Ma J, Boon F, Cain DP, Leung LS. Long-lasting auditory gating deficit accompanied by GABA(B) receptor dysfunction in the hippocampus after early-life limbic seizures in rats. Physiol Behav. 2012 Jun 25;106(4):534-41. doi: 10.1016/j.physbeh.2012.03.033. PubMed PMID: 22504497.